Moderna will reveal the data for its mRNA cancer vaccine next month. Here’s why it matters.
Published . Updated .
One reason that analysts and doctors want to see the data is to better understand how well the personalized treatment works.
Directly affected
- MRNA Moderna
Named in this report.
Indirectly affected
- ACHC ACADIA HEALTHCARE COMPANY INC
GA selected ACHC as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- ASND ASCENDIS PHARMA A/S
GA selected ASND as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- ATYR ATYR PHARMA INC COM NEW
GA selected ATYR as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- BBIO BRIDGEBIO PHARMA INC
GA selected BBIO as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- CRDF CARDIFF ONCOLOGY INC COM
GA selected CRDF as a RELATED security because its canonical security name directly matches this event's themes: oncology. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- DVA DaVita HealthCare Partners, Inc.
GA selected DVA as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
Price reaction, T-5 to T+3
One reason that analysts and doctors want to see the data is to better understand how well the personalized treatment works.
Source: MarketWatch
Moderna (MRNA) since this story, compared with the market
Since the first closing price after “Moderna will reveal the data for its mRNA cancer vaccine next month. Here’s why it matters.,” Moderna (MRNA) is +24.35%. The S&P 500 fund (SPY) is -0.88% over the same days, a +25.24% difference versus the market.
Filings that name Moderna (MRNA) around 21 Sep 2026
- Gilbert Cisneros sell BridgeBio Pharma (BBIO) ($1,001 - $15,000). That is 8 days after publication, inside 30 days. The filing is listed beside the story “Moderna will reveal the data for its mRNA cancer vaccine next month. Here’s why it matters..”
- Maria Elvira Salazar sell Moderna (MRNA) ($1,001 - $15,000). That is 3 days after publication, inside 30 days. The filing is listed beside the story “Moderna will reveal the data for its mRNA cancer vaccine next month. Here’s why it matters..”
- Rohit Khanna buy Moderna (MRNA) ($1,001 - $15,000). That is 17 days before publication, inside 30 days. The filing is listed beside the story “Moderna will reveal the data for its mRNA cancer vaccine next month. Here’s why it matters..”
- Donald J Trump buy Moderna (MRNA) ($1,001 - $15,000). That is 24 days before publication, inside 30 days. The filing is listed beside the story “Moderna will reveal the data for its mRNA cancer vaccine next month. Here’s why it matters..”
- Maria Elvira Salazar buy Moderna (MRNA) ($1,001 - $15,000). That is 33 days before publication, inside 60 days. The filing is listed beside the story “Moderna will reveal the data for its mRNA cancer vaccine next month. Here’s why it matters..”
- Maria Elvira Salazar sell Moderna (MRNA) ($1,001 - $15,000). That is 33 days before publication, inside 60 days. The filing is listed beside the story “Moderna will reveal the data for its mRNA cancer vaccine next month. Here’s why it matters..”
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who gains and who loses around Moderna (MRNA)
Companies mentioned with this story
- MRNA Moderna
For “Moderna will reveal the data for its mRNA cancer vaccine next month. Here’s why it matters.,” Moderna (MRNA) is linked, with no stored direction, high confidence. Reason on file: The reported development directly names MODERNA INC in the headline; GA resolved that company to MRNA
- ACHC Acadia Healthcare
For “Moderna will reveal the data for its mRNA cancer vaccine next month. Here’s why it matters.,” Acadia Healthcare (ACHC) is linked, with no stored direction, medium confidence. Reason on file: GA selected ACHC as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- ASND Ascendis Pharma A/S
Ascendis Pharma A/S (ASND) is linked, with no stored direction, medium confidence in the 21 Sep 2026 story “Moderna will reveal the data for its mRNA cancer vaccine next month. Here’s why it matters..” Reason on file: GA selected ASND as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- ATYR aTYR PHARMA
For “Moderna will reveal the data for its mRNA cancer vaccine next month. Here’s why it matters.,” aTYR PHARMA (ATYR) is linked, with no stored direction, medium confidence. Reason on file: GA selected ATYR as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- BBIO BridgeBio Pharma
In “Moderna will reveal the data for its mRNA cancer vaccine next month. Here’s why it matters.,” BridgeBio Pharma (BBIO) is linked, with no stored direction, medium confidence. Reason on file: GA selected BBIO as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- CRDF Cardiff Oncology
Cardiff Oncology (CRDF) is linked, with no stored direction, medium confidence in the 21 Sep 2026 story “Moderna will reveal the data for its mRNA cancer vaccine next month. Here’s why it matters..” Reason on file: GA selected CRDF as a RELATED security because its canonical security name directly matches this event's themes: oncology. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- DVA Davita
For “Moderna will reveal the data for its mRNA cancer vaccine next month. Here’s why it matters.,” Davita (DVA) is linked, with no stored direction, medium confidence. Reason on file: GA selected DVA as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
Moderna (MRNA)
On 21 Sep 2026, “Moderna will reveal the data for its mRNA cancer vaccine next month. Here’s why it matters.” is the story that connects Moderna (MRNA) to this story.
What ties Moderna (MRNA) to the headline is this: The reported development directly names MODERNA INC in the headline; GA resolved that company to MRNA
Also listed, Acadia Healthcare (ACHC): GA selected ACHC as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
Dates in the story, and the Moderna (MRNA) price range
ACHC traded between 26.75 and 32.03 across 20 sessions. The latest close on file is 30.20. ASND traded between 219.69 and 240.84 across 20 sessions. The latest close on file is 229.99. MRNA traded between 168.05 and 242.18 across 20 sessions. The latest close on file is 226.88.
What the saved facts support for Moderna (MRNA)
46 out of 100
“Moderna will reveal the data for its mRNA cancer vaccine next month. Here’s why it matters.” scores 46 out of 100. The score uses 1 sources, and 7 linked companies.